These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24515947)

  • 1. Methylseleninic acid elevates REDD1 and inhibits prostate cancer cell growth despite AKT activation and mTOR dysregulation in hypoxia.
    Sinha I; Allen JE; Pinto JT; Sinha R
    Cancer Med; 2014 Apr; 3(2):252-64. PubMed ID: 24515947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylseleninic acid downregulates hypoxia-inducible factor-1α in invasive prostate cancer.
    Sinha I; Null K; Wolter W; Suckow MA; King T; Pinto JT; Sinha R
    Int J Cancer; 2012 Mar; 130(6):1430-9. PubMed ID: 21500193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylseleninic acid suppresses pancreatic cancer growth involving multiple pathways.
    Wang L; Hu H; Wang Z; Xiong H; Cheng Y; Liao JD; Deng Y; Lü J
    Nutr Cancer; 2014; 66(2):295-307. PubMed ID: 24447148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells.
    Hu H; Jiang C; Li G; Lü J
    Carcinogenesis; 2005 Aug; 26(8):1374-81. PubMed ID: 15845651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent p21Cip1 induction mediates G(1) cell cycle arrest by methylseleninic acid in DU145 prostate cancer cells.
    Wang Z; Lee HJ; Chai Y; Hu H; Wang L; Zhang Y; Jiang C; Lü J
    Curr Cancer Drug Targets; 2010 May; 10(3):307-18. PubMed ID: 20370687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylseleninic acid overcomes programmed death-ligand 1-mediated resistance of prostate cancer and lung cancer.
    Hu W; Ma Y; Zhao C; Yin S; Hu H
    Mol Carcinog; 2021 Nov; 60(11):746-757. PubMed ID: 34411338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells.
    Jiang C; Wang Z; Ganther H; Lü J
    Mol Cancer Ther; 2002 Oct; 1(12):1059-66. PubMed ID: 12481429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling.
    Wang Z; Jiang C; Ganther H; Lü J
    Cancer Res; 2001 Oct; 61(19):7171-8. PubMed ID: 11585751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylseleninic Acid Superactivates p53-Senescence Cancer Progression Barrier in Prostate Lesions of Pten-Knockout Mouse.
    Wang L; Guo X; Wang J; Jiang C; Bosland MC; Lü J; Deng Y
    Cancer Prev Res (Phila); 2016 Jan; 9(1):35-42. PubMed ID: 26511486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells.
    Hu H; Jiang C; Ip C; Rustum YM; Lü J
    Clin Cancer Res; 2005 Mar; 11(6):2379-88. PubMed ID: 15788689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin.
    Hu H; Li GX; Wang L; Watts J; Combs GF; Lü J
    Clin Cancer Res; 2008 Feb; 14(4):1150-8. PubMed ID: 18281549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inositol hexaphosphate suppresses growth and induces apoptosis in prostate carcinoma cells in culture and nude mouse xenograft: PI3K-Akt pathway as potential target.
    Gu M; Roy S; Raina K; Agarwal C; Agarwal R
    Cancer Res; 2009 Dec; 69(24):9465-72. PubMed ID: 19920184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential involvement of reactive oxygen species in apoptosis induced by two classes of selenium compounds in human prostate cancer cells.
    Li GX; Hu H; Jiang C; Schuster T; Lü J
    Int J Cancer; 2007 May; 120(9):2034-43. PubMed ID: 17230520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylseleninic acid inhibits microvascular endothelial G1 cell cycle progression and decreases tumor microvessel density.
    Wang Z; Hu H; Li G; Lee HJ; Jiang C; Kim SH; Lü J
    Int J Cancer; 2008 Jan; 122(1):15-24. PubMed ID: 17847021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shikonin suppresses proliferation and induces cell cycle arrest through the inhibition of hypoxia-inducible factor-1α signaling.
    Li MY; Mi C; Wang KS; Wang Z; Zuo HX; Piao LX; Xu GH; Li X; Ma J; Jin X
    Chem Biol Interact; 2017 Aug; 274():58-67. PubMed ID: 28684144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursolic Acid Induces Apoptosis of Prostate Cancer Cells via the PI3K/Akt/mTOR Pathway.
    Meng Y; Lin ZM; Ge N; Zhang DL; Huang J; Kong F
    Am J Chin Med; 2015; 43(7):1471-86. PubMed ID: 26503559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperlongumine promotes autophagy via inhibition of Akt/mTOR signalling and mediates cancer cell death.
    Makhov P; Golovine K; Teper E; Kutikov A; Mehrazin R; Corcoran A; Tulin A; Uzzo RG; Kolenko VM
    Br J Cancer; 2014 Feb; 110(4):899-907. PubMed ID: 24434432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The quinoline imidoselenocarbamate EI201 blocks the AKT/mTOR pathway and targets cancer stem cells leading to a strong antitumor activity.
    Ibáñez E; Agliano A; Prior C; Nguewa P; Redrado M; González-Zubeldia I; Plano D; Palop JA; Sanmartín C; Calvo A
    Curr Med Chem; 2012; 19(18):3031-43. PubMed ID: 22455594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR.
    Deeb D; Gao X; Jiang H; Dulchavsky SA; Gautam SC
    Prostate; 2009 Jun; 69(8):851-60. PubMed ID: 19189297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salidroside protects against hydrogen peroxide-induced injury in HUVECs via the regulation of REDD1 and mTOR activation.
    Xu MC; Shi HM; Wang H; Gao XF
    Mol Med Rep; 2013 Jul; 8(1):147-53. PubMed ID: 23660824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.